Reversibility of joint thickening in acromegalic patients: An ultrasonography study

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 6, 1998, Pages 2121-2125

  Colao, Annamaria ^a   Marzullo, Paolo ^a   Vallone, Gianfranco ^a   Marinò, Valeria ^a   Annecchino, Massimo ^a   Ferone, Diego ^a   De Brasi, Davide ^a   Scarpa, Raffaele ^a   Oriente, Pasquale ^a   Lombardi, Gaetano ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; OCTREOTIDE;

ACROMEGALY; ADULT; AGED; ARTHROPATHY; ARTICLE; ARTICULAR CARTILAGE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DOSE TIME EFFECT RELATION; DRUG EFFICACY; ECHOGRAPHY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PRIORITY JOURNAL; THICKNESS;

EID: 15444351383     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.83.6.4865     Document Type: Article

References (20)

1. Marie P. 1886 Sur deux cas d'acromégalie. Rev Med. 6:297-299.
2. Waine H, Bonnet GA, Bauer W. 1945 Joint disease associated with acromegaly. Am J Med Sci. 209:671-678.
3. Kellgren JH, Ball J, Tutton GK. 1952 The articular and other limb changes in acromegaly. Q J Med. 21:405-423.
4. Bluestone R, Bywaters E, Hartog M, Holt PJL, Hyde S. 1971 Acromegalic arthropathy. Ann Rheum Dis. 30:243-258.
5. Detenbeck L, Tressler H, O'Duffy J, Randall RV. 1973 Peripheral joint manifestations of acromegaly. Clin Orthop. 91:119-127.
6. Holt P. 1981 Locomotor abnormalities in acromegaly. Clin Rheum Dis. 7:689-709.
7. Johanson NA, Vigorita VJ, Goldman AB, Slavati EA. 1983 Acromegalic arthropathy of the hip. Clin Orthop. 173:130-139.
8. Lacks S, Jacobs RP. 1986 Acromegalic arthropathy: a reversible rheumatic disease. J Rheumatol. 13:634-636.
9. Layton MW, Fudman EJ, Barkan A, Braunstein EM, Fox IH. 1988 Acromegalic arthropathy: characteristics and response to therapy. Arthritis Rheum. 31:1022-1027.
10. Manger B, Kalden J. 1995 Joint and connective tissue ultrasonography-a rheumatologic bedside procedure? Arthritis Rheum. 38:736-742.
11. Colao A, Merola B, Ferone D, Lombardi G. 1997 Acromegaly. J Clin Endocrinol Metab. 84:2777-2781.
12. Colao A, Ferone D, Lastoria S, et al. 1996 Prediction of efficacy of octreotide therapy in patients with acromegaly. J Clin Endocrinol Metab. 81:1356-1362.
13. Barkan A. 1997 Acromegalic arthropathy and sleep apnea. J Endocrinol 155:541-544.
14. Dons RF, Rosselet P, Pastakia B, Doppman J, Gorden P. 1988 Arthropathy in acromegalic patients before and after treatment: a long-term follow-up study. Clin Endocrinol (Oxf). 28:515-524.
15. Chrisman OD. 1975 The effect of growth hormone on established cartilage lesions. Clin Orthop. 107:232-238.
16. Sledge CB. 1973 Growth hormone and articular cartilage. Fed Proc. 32:1503-1505.
17. Lamberts SWJ, van Der Lely AJ, de Herder WW, Hofland J. 1996 Octreotide. N Engl J Med. 334:246-254.
18. Melmed S, Ho K, Klibanski A, Reichlin S, Thorner M. 1995 Recent advances in pathology, diagnosis and management of acromegaly. J Clin Endocrinol Metab. 80:3395-3402.
19. Lamberts SWJ, Uitterlinden P, Verschoor L, van Dongen KL, del Pozo E. 1985 Long-term treatment of acromegaly with the somatostatin analogue SMS 201-995. N Engl J Med. 313:1576-1580.
20. Rolfsema F, Vandulken H, Frolich M. 1986 Long-term result of transsphenoidal pituitary microsurgery in 60 acromegalic patients. Clin Endocrinol (Oxf). 23:555-565.